How common is Lung cancer?

['Klausieties itū lopu']

Cik izplateits ir plaušu viezs?

Plaušu vieža ir vīns nu vysizplateituokūs vieža veidu vysā pasaulī.

Piec Pasauļa veseleibys organizacejis (PVO) ziņu, plaušu vieža ir golvonais īmeslis, kas izraisa vieža smierts pasaulī, aptuvenais skaits ir 1,8 miļjoni jaunu saslimšonu i 1,6 miļjoni smierts 2020. godā.

ASV tys ir ūtrais vysizplateituokais vieža veids gon veirīšim, gon sīvītem, ar aptuvanū 228 810 jaunūs gadīņu 2021. godā.

Plaušu vieža saslimsteibys i miersteibys ruodeituoji vysaiduos regionuos atsaškir, leluoki ruodeituoji ir atteisteituos vaļstīs i veirīšim.

Vystik pādejūs godūs plaušu vieža saslimsteiba ir mazynojusēs deļ mozuoka dūmuotuoju skaita.

['Nūruodis']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chang S, Dai M, Ren JS, Chen YH, Guo LW: [Estimates and prediction on incidence, mortality and prevalence of lung cancer in China in 2008]. Zhonghua Liu Xing Bing Xue Za Zhi. 2012, 33 (4): 391-4.

Nguyen RH, Vater LB, Timsina LR, Durm GA, Rupp K, Wright K, Spitznagle MH, Paul B, Jalal SI, Carter-Harris L, Hudmon KS, Hanna NH, Loehrer PJ, Ceppa DP: Impact of smoke-free ordinance strength on smoking prevalence and lung cancer incidence. PLoS One. 2021, 16 (4): e0250285.

Tabatabai MA, Kengwoung-Keumo JJ, Oates GR, Guemmegne JT, Akinlawon A, Ekadi G, Fouad MN, Singh KP: Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer in the United States: A Longitudinal Analysis. PLoS One. , 11 (9): e0162949.

Karim-Kos HE, Janssen-Heijnen ML, van Iersel CA, van der Meer RM, de Vries E, Coebergh JW: The beginning of the end of the lung cancer epidemic in Dutch women? Int J Cancer. 2008, 123 (6): 1472-5.

Putila JJ, Guo NL: Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS One. 2011, 6 (10): e25886.

Strand TE, Malayeri C, Eskonsipo PK, Grimsrud TK, Norstein J, Grotmol T: Adolescent smoking and trends in lung cancer incidence among young adults in Norway 1954-1998. Cancer Causes Control. 2004, 15 (1): 27-33.

['Atsaceišona nu: medicinys']

['Itei interneta vītne ir dūmuota tikai izgleiteibys i informacejis īmeslim, i tei nateik skaiteita par medicinys pīduovuojumu voi profesionalu pakolpuojumu.']

['Pīduovuotū informaceju nadreikst lītuot, kab diagnosticātu voi izuorstātu kaidu slimeibu, i tim, kas meklej personeigu mediciniskū padūmu, juosazynoj ar licencātu uorstu.']

['Juopīzeist, ka neironu teikls, kas generej atbiļdis iz vaicuojumim, ir eipaši napareizs, kod runoj par skaitliskū saturu, par pīmāru, par konkretu slimeibu diagnozātūs cylvāku skaitu.']

['Vysod meklejit padumu nu sova uorsta voi cyta kvalificāta uorsta, kab saprostu jiusu slimeibu. Nikod naatsakuortojit profesionalū uorsta padumu voi aizkavejit tū mekliešonu deļtuo, ka esat koč kū izlasiejs itamā interneta vītnē. Ka jiusim ruodīs, ka jiusim var byut uorsteibys uorkuortys situaceja, zvaniet 911 voi īīt tyvuokajā uorstnīceibys centrā.']

['Atsaceišona: autortiesības']

['1998. goda Digitaluo tyukstūšgadis autoru tīseibu lykums, 17 U.S.C. § 512 (DMCA) nūdrūsynoj tīseibu aizstuoviešonu autoru tīseibu turātuojim, kuri skaita, ka materialā, kas pasaruoda iz škārsteikla, ir puorkuoptys jūs tīseibys saskaņā ar ASV autoru tīseibu lykumim. ']

['Ka jius iz lobu tycat, ka kaids saturs voi materials, kas ir pīejams saisteibā ar myusu sātom voi pakolpuojumim, puorkuop jiusu autortiesības, jius (voi jiusu aģents) jiusim var syuteit paziņuojumu, kurā lyugts svīgt itū saturu voi materialu voi bloķēt pīeju tam.']

['Paziņuojumi ir juonūsyuta e-postā (vērtīs sadaļu "Kontakti" e-posta adresei).']

['DMCA prasej, kab jiusu paziņuojumā par īspiejamu autortiesību puorkuopumu byutu īkļauta itei informaceja: (1) ar autortiesībām aizsorguotuo dorba aproksts, kas ir īspiejamuos puorkuopuma objekts; (2) īspiejamuos puorkuopuma satura aproksts i informaceja, kas ir pīteikama, kab ļautu mums atrast saturu; (3) jiusu kontaktinformaceja, tymā skaitā adrese, telefona numurs i e-posta adrese; (4) apstyprynuojums, ka jius asat puorlīcynuots, ka saturs tai, kai ir ībyldts, nav atļauts ar autortiesību eipašnīka voi juo aģenta voi kaida lykuma atbolstu; ']

['5. aplīcynuojumu, ka jiusu informaceja ir pareiza i ka jiusim ir tīseibys izmontuot autortīseibys, kuruos ir nūlīgts lītuot;']

['i 6) fizisks voi elektronisks autortīseibu turātuoja voi personas, kas ir pilnvarota dorbuotīs autortīseibu turātuoja vuordā, paraksts.']

['Ka naatsaroksta vysa īprīkš mynātuo informaceja, var nūtikt kavējums tovu škieršonūs.']

['Kontakti ar mums']

['Lyudzu, syutiet mums e-postu ar sevkuru vaicuojumu/ieteikumu.']

How common is lung cancer?

Lung cancer is one of the most common types of cancer worldwide.

According to the World Health Organization (WHO), lung cancer is the leading cause of cancer deaths globally, with an estimated 1.8 million new cases and 1.6 million deaths in 2020.

In the United States, it is the second most common cancer in both men and women, with an estimated 228,810 new cases in 2021.

The incidence and mortality rates of lung cancer vary by region, with higher rates in developed countries and among males.

However, the incidence of lung cancer has been decreasing in recent years due to decreased smoking prevalence.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.